Medicine
Posaconazole 100 mg delayed-release tablet
Posaconazole 100 mg delayed-release tablet is a generic prescription medicine for oral use, made by 18 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F).
Key facts
- Active ingredient (INN)
- Posaconazole
- Brand
- Sold under the generic name
- Strength
- 100 mg
- Dosage form
- Delayed-release tablet
- Route
- Oral
- Packs
- 60 tablets, 30 tablets, 24 tablets and 24 more
- Manufacturers
- Aurobindo PharmaIndiaBioconIndiaCamber PharmaceuticalsIndiaDr. Reddy's LaboratoriesIndiaLupinIndiaBryant Ranch PrepackLannettAmerican Health PackagingAmneal Pharmaceuticals NYAtlantic Biologicals
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J02AC04 Posaconazole
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 28 August 2019
- Identifiers
- RxCUI 1482908DailyMed set ID d8d8dd03-46b5-bd26-bb27-7ca31d8c3326, d2daba09-f1c2-4764-a567-1291be4892b9, 94a9b028-a2bc-4f41-884d-2d6c536881fc +17NDC 43598-470, 72162-2243, 0527-2133 +17Application ANDA212500, ANDA216488, ANDA212411 +6
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 60 tablet, delayed release in 1 bottle | 59651-596-60 | Aurobindo PharmaIndia | 18 July 2024 |
| 60 tablet, delayed release in 1 bottle | 70377-038-11 | BioconIndia | 8 March 2022 |
| 60 tablet, delayed release in 1 bottle | 31722-677-60 | Camber PharmaceuticalsIndia | 8 December 2022 |
| 60 tablet, delayed release in 1 bottle | 43598-470-60 | Dr. Reddy's LaboratoriesIndia | 7 April 2022 |
| 60 tablet, delayed release in 1 bottle | 70748-258-07 | LupinIndia | 17 February 2021 |
| 60 tablet, delayed release in 1 bottle | 73141-023-02 | A2A Integrated Pharmaceuticals | 16 May 2024 |
| 30 tablet, delayed release in 1 bottle | 69238-1476-3 | Amneal Pharmaceuticals NY | 30 December 2022 |
| 60 tablet, delayed release in 1 bottle | 69238-1476-6 | Amneal Pharmaceuticals NY | 30 December 2022 |
| 60 tablet, delayed release in 1 bottle | 72319-023-02 | i3 Pharmaceuticals | 15 September 2023 |
| 24 tablet, delayed release in 1 carton | 0527-2133-30 | Lannett | 31 January 2021 |
| 60 tablet, delayed release in 1 bottle | 0527-2133-35 | Lannett | 28 August 2019 |
| 1000 tablet, delayed release in 1 bottle | 0527-2133-43 | Lannett | 28 August 2019 |
| 60 tablet, delayed release in 1 bottle | 0406-7711-60 | SpecGx | 10 May 2022 |
| 60 tablet, delayed release in 1 bottle | 71335-2665-1 | Bryant Ranch Prepack | 26 June 2025 |
| 60 tablet, delayed release in 1 bottle | 71335-2930-1 | Bryant Ranch Prepack | 11 November 2025 |
| 20 tablet, delayed release in 1 bottle | 72162-2243-2 | Bryant Ranch Prepack | 19 January 2024 |
| 60 tablet, delayed release in 1 bottle | 72162-2243-6 | Bryant Ranch Prepack | 19 January 2024 |
| 30 blister pack in 1 box, unit-dose / 1 tablet, delayed release in 1 blister pack | 60687-523-21 | American Health Packaging | 11 June 2020 |
| 20 blister pack in 1 box, unit-dose / 1 tablet, delayed release in 1 blister pack | 60687-523-94 | American Health Packaging | 3 March 2022 |
| 100 pouch in 1 box, unit-dose / 1 tablet, delayed release in 1 pouch | 17856-2133-1 | Atlantic Biologicals | 9 May 2024 |
| 59 pouch in 1 box / 1 tablet, delayed release in 1 pouch | 17856-2133-5 | Atlantic Biologicals | 20 April 2026 |
| 60 tablet, delayed release in 1 bottle | 42291-919-60 | AvKARE | 20 April 2023 |
| 20 blister pack in 1 box / 1 tablet, delayed release in 1 blister pack | 50268-683-12 | AvPAK | 9 May 2022 |
| 60 tablet, delayed release in 1 bottle | 51407-676-60 | Golden State Medical Supply | 12 September 2022 |
| 30 blister pack in 1 carton / 1 tablet, delayed release in 1 blister pack | 0904-7149-04 | Major Pharmaceuticals | 3 February 2021 |
| 20 blister pack in 1 carton / 1 tablet, delayed release in 1 blister pack | 0904-7149-10 | Major Pharmaceuticals | 3 February 2021 |
| 60 tablet, delayed release in 1 bottle | 16714-535-01 | NorthStar RxLLC | 2 April 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Posaconazole
Clinical summary
Posaconazole is an azole antifungal indicated as follows, among other approved uses. It is available as delayed-release tablets, injection and tablets for oral and intravenous use. MedsAcross supplies Posaconazole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PosaconazoleFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- POSACONAZOLE prescribing information (Endo) · U.S. National Library of Medicine, DailyMed
- Noxafil: European public assessment report (EPAR) · European Medicines Agency
- Posaconazole Accord: European public assessment report (EPAR) · European Medicines Agency
Need Posaconazole 100 mg delayed-release tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.